Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
NEBIVOLOL HYDROCHLORIDE
(2007)
Small molecule
Beta-1 adrenergic receptor antagonist
ORAL
Approved
Hypertension; Stroke
NEBIVOLOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2007
UNII:
JGS34J7L9I
Molecule Type:
Small molecule
Molecular Formula:
C22H26ClF2NO4
Molecular Weight:
441.9
AlogP:
2.36
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LEVOCETIRIZINE DIHYDROCHLORIDE
(2007)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Conjunctivitis, Allergic; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Skin Manifestations; Urticaria
LEVOCETIRIZINE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2007
UNII:
SOD6A38AGA
Molecule Type:
Small molecule
Molecular Formula:
C21H27Cl3N2O3
Molecular Weight:
461.82
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DORIPENEM
(2007)
Small molecule
Bacterial penicillin-binding protein inhibitor
INTRAVENOUS
Approved
Bacterial Infections; Intraabdominal Infections; Pyelonephritis; Urinary Tract Infections
DORIPENEM
×
Maximum Phase:
4
First Approval:
2007
UNII:
BHV525JOBH
Molecule Type:
Small molecule
Molecular Formula:
C15H24N4O6S2
Molecular Weight:
420.51
AlogP:
-1.6
PSA:
162.06
HBD:
5.0
HBA:
#RotB:
7.0
Source:
LAPATINIB DITOSYLATE
(2007)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Breast Neoplasms
LAPATINIB DITOSYLATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
G873GX646R
Molecule Type:
Small molecule
Molecular Formula:
C43H44ClFN4O11S3
Molecular Weight:
943.49
AlogP:
6.14
PSA:
106.35
HBD:
2.0
HBA:
#RotB:
11.0
Source:
LEVOCETIRIZINE
(2007)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
LEVOCETIRIZINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
6U5EA9RT2O
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TEMSIROLIMUS
(2007)
Small molecule
FK506-binding protein 1A inhibitor
INTRAVENOUS
Approved
Carcinoma, Renal Cell; Neoplasms
TEMSIROLIMUS
×
Maximum Phase:
4
First Approval:
2007
UNII:
624KN6GM2T
Molecule Type:
Small molecule
Molecular Formula:
C56H87NO16
Molecular Weight:
1030.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DICLOFENAC EPOLAMINE
(2007)
Small molecule
Cyclooxygenase inhibitor
TOPICAL
Approved
Acute Pain
DICLOFENAC EPOLAMINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
X5F8EKL9ZG
Molecule Type:
Small molecule
Molecular Formula:
C20H24Cl2N2O3
Molecular Weight:
411.33
AlogP:
4.36
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SAPROPTERIN
(2007)
Small molecule
Unknown
Unknown
Approved
Unknown
SAPROPTERIN
×
Maximum Phase:
4
First Approval:
2007
UNII:
EGX657432I
Molecule Type:
Small molecule
Molecular Formula:
C9H15N5O3
Molecular Weight:
241.25
AlogP:
-1.29
PSA:
136.55
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AMMONIA N 13
(2007)
Small molecule
Diagnostic agent
Unknown
Approved
Coronary Artery Disease
AMMONIA N 13
×
Maximum Phase:
4
First Approval:
2007
UNII:
9OQO0E343Z
Molecule Type:
Small molecule
Molecular Formula:
H3N
Molecular Weight:
16.03
AlogP:
0.16
PSA:
35.0
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ROTIGOTINE
(2007)
Small molecule
D2-like dopamine receptor agonist
TRANSDERMAL
Approved
Parkinson Disease; Restless Legs Syndrome
ROTIGOTINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
87T4T8BO2E
Molecule Type:
Small molecule
Molecular Formula:
C19H25NOS
Molecular Weight:
315.48
AlogP:
4.27
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TETRABENAZINE
(2008)
Small molecule
Synaptic vesicular amine transporter inhibitor
ORAL
Approved
Huntington Disease
TETRABENAZINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
Z9O08YRN8O
Molecule Type:
Small molecule
Molecular Formula:
C19H27NO3
Molecular Weight:
317.43
AlogP:
3.24
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
4.0
Source:
IOBENGUANE SULFATE I 123
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
IOBENGUANE SULFATE I 123
×
Maximum Phase:
4
First Approval:
2008
UNII:
23X1185WBO
Molecule Type:
Small molecule
Molecular Formula:
C16H22I2N6O4S
Molecular Weight:
640.27
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ERLOSAMIDE
(2008)
Small molecule
Sodium channel alpha subunit blocker
Unknown
Approved
Epilepsy; Seizures
ERLOSAMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
563KS2PQY5
Molecule Type:
Small molecule
Molecular Formula:
C13H18N2O3
Molecular Weight:
250.3
AlogP:
0.45
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
6.0
Source:
FOSAPREPITANT DIMEGLUMINE
(2008)
Small molecule
Neurokinin 1 receptor antagonist
INJECTION; INTRAVENOUS; UNKNOWN
Approved
Neoplasms; Postoperative Nausea and Vomiting
FOSAPREPITANT DIMEGLUMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
D35FM8T64X
Molecule Type:
Small molecule
Molecular Formula:
C37H56F7N6O16P
Molecular Weight:
1004.84
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GADOXETATE DISODIUM
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Unknown
GADOXETATE DISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
HOY74VZE0M
Molecule Type:
Small molecule
Molecular Formula:
C23H29GdN3NaO10
Molecular Weight:
687.74
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FENOFIBRIC ACID
(2008)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Diabetes Mellitus, Type 2; Hypercholesterolemia
FENOFIBRIC ACID
×
Maximum Phase:
4
First Approval:
2008
UNII:
BGF9MN2HU1
Molecule Type:
Small molecule
Molecular Formula:
C17H15ClO4
Molecular Weight:
318.76
AlogP:
3.81
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CHOLINE FENOFIBRATE
(2008)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Cardiovascular Diseases
CHOLINE FENOFIBRATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
4BMH7IZT98
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClNO5
Molecular Weight:
421.92
AlogP:
3.81
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ELTROMBOPAG OLAMINE
(2008)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Anemia, Aplastic; Hepatitis C, Chronic; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
ELTROMBOPAG OLAMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
4U07F515LG
Molecule Type:
Small molecule
Molecular Formula:
C29H36N6O6
Molecular Weight:
564.64
AlogP:
4.56
PSA:
114.59
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BUPROPION HYDROBROMIDE
(2008)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major
BUPROPION HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
E70G3G5863
Molecule Type:
Small molecule
Molecular Formula:
C13H19BrClNO
Molecular Weight:
320.66
AlogP:
3.3
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
METHYL SALICYLATE
(2008)
Small molecule
Unknown
Unknown
Approved
Arthritis; Back Pain; Bursitis; Contusions; Muscle Cramp; Myalgia; Pain; Sprains and Strains; Tendinopathy; Wounds and Injuries
METHYL SALICYLATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
LAV5U5022Y
Molecule Type:
Small molecule
Molecular Formula:
C8H8O3
Molecular Weight:
152.15
AlogP:
1.18
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BENDAMUSTINE
(2008)
Small molecule
Unknown
IV (INFUSION)
Approved
Neoplasms
BENDAMUSTINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
9266D9P3PQ
Molecule Type:
Small molecule
Molecular Formula:
C16H21Cl2N3O2
Molecular Weight:
358.27
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PLERIXAFOR
(2008)
Small molecule
C-X-C chemokine receptor type 4 partial agonist
SUBCUTANEOUS
Approved
Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms
PLERIXAFOR
×
Maximum Phase:
4
First Approval:
2008
UNII:
S915P5499N
Molecule Type:
Small molecule
Molecular Formula:
C28H54N8
Molecular Weight:
502.8
AlogP:
0.42
PSA:
78.66
HBD:
6.0
HBA:
#RotB:
4.0
Source:
DESVENLAFAXINE SUCCINATE
(2008)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder, Major
DESVENLAFAXINE SUCCINATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
ZB22ENF0XR
Molecule Type:
Small molecule
Molecular Formula:
C20H31NO6
Molecular Weight:
381.47
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SILODOSIN
(2008)
Small molecule
Alpha-1a adrenergic receptor antagonist
ORAL
Approved
Prostatic Hyperplasia
SILODOSIN
×
Maximum Phase:
4
First Approval:
2008
UNII:
CUZ39LUY82
Molecule Type:
Small molecule
Molecular Formula:
C25H32F3N3O4
Molecular Weight:
495.54
AlogP:
3.07
PSA:
97.05
HBD:
3.0
HBA:
#RotB:
13.0
Source:
FESOTERODINE
(2008)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
FESOTERODINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
621G617227
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO3
Molecular Weight:
411.59
AlogP:
5.38
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ETRAVIRINE
(2008)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV; HIV Infections; Virus Diseases
ETRAVIRINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
0C50HW4FO1
Molecule Type:
Small molecule
Molecular Formula:
C20H15BrN6O
Molecular Weight:
435.29
AlogP:
4.72
PSA:
120.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LEVOLEUCOVORIN
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Anemia; Colorectal Neoplasms; Osteosarcoma
LEVOLEUCOVORIN
×
Maximum Phase:
4
First Approval:
2008
UNII:
990S25980Y
Molecule Type:
Small molecule
Molecular Formula:
C20H23N7O7
Molecular Weight:
473.45
AlogP:
-0.73
PSA:
219.84
HBD:
7.0
HBA:
#RotB:
10.0
Source:
GADOFOSVESET TRISODIUM
(2008)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
GADOFOSVESET TRISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
XM33Q67UVH
Molecule Type:
Small molecule
Molecular Formula:
C33H38GdN3Na3O14P
Molecular Weight:
957.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FOSPROPOFOL DISODIUM
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL DISODIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
30868AY0IF
Molecule Type:
Small molecule
Molecular Formula:
C13H19Na2O5P
Molecular Weight:
332.24
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CLEVIDIPINE
(2008)
Small molecule
Voltage-gated L-type calcium channel blocker
INTRAVENOUS
Approved
Cardiovascular Diseases
CLEVIDIPINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
19O2GP3B7Q
Molecule Type:
Small molecule
Molecular Formula:
C21H23Cl2NO6
Molecular Weight:
456.32
AlogP:
4.25
PSA:
90.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
OXIGLUTATIONE
(2008)
Small molecule
Glutathione reductase
Unknown
Approved
Unknown
OXIGLUTATIONE
×
Maximum Phase:
4
First Approval:
2008
UNII:
ULW86O013H
Molecule Type:
Small molecule
Molecular Formula:
C20H32N6O12S2
Molecular Weight:
612.64
AlogP:
-3.88
PSA:
317.64
HBD:
10.0
HBA:
#RotB:
21.0
Source:
DIFLUPREDNATE
(2008)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Inflammation; Uveitis, Anterior
DIFLUPREDNATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
S8A06QG2QE
Molecule Type:
Small molecule
Molecular Formula:
C27H34F2O7
Molecular Weight:
508.56
AlogP:
3.52
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
6.0
Source:
REGADENOSON
(2008)
Small molecule
Adenosine A2a receptor agonist
INTRAVENOUS
Approved
Cardiovascular Diseases
REGADENOSON
×
Maximum Phase:
4
First Approval:
2008
UNII:
2XLN4Y044H
Molecule Type:
Small molecule
Molecular Formula:
C15H20N8O6
Molecular Weight:
408.38
AlogP:
-2.43
PSA:
186.46
HBD:
5.0
HBA:
#RotB:
4.0
Source:
BENDAMUSTINE HYDROCHLORIDE
(2008)
Small molecule
DNA inhibitor
INJECTION; IV (INFUSION)
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin
BENDAMUSTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
981Y8SX18M
Molecule Type:
Small molecule
Molecular Formula:
C16H22Cl3N3O2
Molecular Weight:
394.73
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
GADOFOSVESET
(2008)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
GADOFOSVESET
×
Maximum Phase:
4
First Approval:
2008
UNII:
E65RW73PHS
Molecule Type:
Small molecule
Molecular Formula:
C33H44GdN3O14P+3
Molecular Weight:
894.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DESVENLAFAXINE
(2008)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major
DESVENLAFAXINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
NG99554ANW
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO2
Molecular Weight:
263.38
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
57
58
59
60
61
62
63
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA